Three FDA offices open doors in China
This article was originally published in The Silver Sheet
FDA opened three new offices in China the week of Nov. 17 in a move approved by the U.S. State Department in March. The eight FDA senior staffers selected to work in the Beijing, Guangzhou and Shanghai offices are inspectors and senior technical experts in foods, medicines and medical devices, the U.S. Department of Health and Human Services notes. "By having a presence in other parts of the world, we can work more closely with manufacturers and other governments, better share best practices and further ensure ... quality and safety," says HHS Secretary Mike Leavitt, who, along with FDA Commissioner Andrew von Eschenbach, traveled to the three cities late last month to meet with manufacturers and Chinese government officials to discuss policy and governance reforms aimed at improving the safety of medical products and food. HHS also is working to have an FDA presence in India, Europe, Latin America and the Middle East
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.